Global Molecular Diagnosis of Tumors Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Molecular Diagnosis of Tumors
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Molecular Diagnosis of Tumors by Type
  • 1.3.1 Overview: Global Molecular Diagnosis of Tumors Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Molecular Diagnosis of Tumors Consumption Value Market Share by Type in 2022
  • 1.3.3 NGS-Based
  • 1.3.4 PCR-Based
• 1.4 Global Molecular Diagnosis of Tumors Market by Application
  • 1.4.1 Overview: Global Molecular Diagnosis of Tumors Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Hospitals
  • 1.4.3 Diagnostic Centers
  • 1.4.4 Others
• 1.5 Global Molecular Diagnosis of Tumors Market Size & Forecast
• 1.6 Global Molecular Diagnosis of Tumors Market Size and Forecast by Region
  • 1.6.1 Global Molecular Diagnosis of Tumors Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Molecular Diagnosis of Tumors Market Size by Region, (2018-2029)
  • 1.6.3 North America Molecular Diagnosis of Tumors Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Molecular Diagnosis of Tumors Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Molecular Diagnosis of Tumors Market Size and Prospect (2018-2029)
  • 1.6.6 South America Molecular Diagnosis of Tumors Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Molecular Diagnosis of Tumors Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Abbott Laboratories
  • 2.1.1 Abbott Laboratories Details
  • 2.1.2 Abbott Laboratories Major Business
  • 2.1.3 Abbott Laboratories Molecular Diagnosis of Tumors Product and Solutions
  • 2.1.4 Abbott Laboratories Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Abbott Laboratories Recent Developments and Future Plans
• 2.2 Roche Holding
  • 2.2.1 Roche Holding Details
  • 2.2.2 Roche Holding Major Business
  • 2.2.3 Roche Holding Molecular Diagnosis of Tumors Product and Solutions
  • 2.2.4 Roche Holding Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Roche Holding Recent Developments and Future Plans
• 2.3 Thermo Fisher Scientific
  • 2.3.1 Thermo Fisher Scientific Details
  • 2.3.2 Thermo Fisher Scientific Major Business
  • 2.3.3 Thermo Fisher Scientific Molecular Diagnosis of Tumors Product and Solutions
  • 2.3.4 Thermo Fisher Scientific Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.4 Danaher Corporation
  • 2.4.1 Danaher Corporation Details
  • 2.4.2 Danaher Corporation Major Business
  • 2.4.3 Danaher Corporation Molecular Diagnosis of Tumors Product and Solutions
  • 2.4.4 Danaher Corporation Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Danaher Corporation Recent Developments and Future Plans
• 2.5 Veracyte
  • 2.5.1 Veracyte Details
  • 2.5.2 Veracyte Major Business
  • 2.5.3 Veracyte Molecular Diagnosis of Tumors Product and Solutions
  • 2.5.4 Veracyte Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Veracyte Recent Developments and Future Plans
• 2.6 TBG Diagnostics
  • 2.6.1 TBG Diagnostics Details
  • 2.6.2 TBG Diagnostics Major Business
  • 2.6.3 TBG Diagnostics Molecular Diagnosis of Tumors Product and Solutions
  • 2.6.4 TBG Diagnostics Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 TBG Diagnostics Recent Developments and Future Plans
• 2.7 Agilient Technologies
  • 2.7.1 Agilient Technologies Details
  • 2.7.2 Agilient Technologies Major Business
  • 2.7.3 Agilient Technologies Molecular Diagnosis of Tumors Product and Solutions
  • 2.7.4 Agilient Technologies Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Agilient Technologies Recent Developments and Future Plans
• 2.8 Illumina
  • 2.8.1 Illumina Details
  • 2.8.2 Illumina Major Business
  • 2.8.3 Illumina Molecular Diagnosis of Tumors Product and Solutions
  • 2.8.4 Illumina Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Illumina Recent Developments and Future Plans
• 2.9 Genecast
  • 2.9.1 Genecast Details
  • 2.9.2 Genecast Major Business
  • 2.9.3 Genecast Molecular Diagnosis of Tumors Product and Solutions
  • 2.9.4 Genecast Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Genecast Recent Developments and Future Plans
• 2.10 Burning Rock Biotech
  • 2.10.1 Burning Rock Biotech Details
  • 2.10.2 Burning Rock Biotech Major Business
  • 2.10.3 Burning Rock Biotech Molecular Diagnosis of Tumors Product and Solutions
  • 2.10.4 Burning Rock Biotech Molecular Diagnosis of Tumors Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Burning Rock Biotech Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Molecular Diagnosis of Tumors Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Molecular Diagnosis of Tumors by Company Revenue
  • 3.2.2 Top 3 Molecular Diagnosis of Tumors Players Market Share in 2022
  • 3.2.3 Top 6 Molecular Diagnosis of Tumors Players Market Share in 2022
• 3.3 Molecular Diagnosis of Tumors Market: Overall Company Footprint Analysis
  • 3.3.1 Molecular Diagnosis of Tumors Market: Region Footprint
  • 3.3.2 Molecular Diagnosis of Tumors Market: Company Product Type Footprint
  • 3.3.3 Molecular Diagnosis of Tumors Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Molecular Diagnosis of Tumors Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Molecular Diagnosis of Tumors Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Molecular Diagnosis of Tumors Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Molecular Diagnosis of Tumors Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Molecular Diagnosis of Tumors Consumption Value by Type (2018-2029)
• 6.2 North America Molecular Diagnosis of Tumors Consumption Value by Application (2018-2029)
• 6.3 North America Molecular Diagnosis of Tumors Market Size by Country
  • 6.3.1 North America Molecular Diagnosis of Tumors Consumption Value by Country (2018-2029)
  • 6.3.2 United States Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Molecular Diagnosis of Tumors Consumption Value by Type (2018-2029)
• 7.2 Europe Molecular Diagnosis of Tumors Consumption Value by Application (2018-2029)
• 7.3 Europe Molecular Diagnosis of Tumors Market Size by Country
  • 7.3.1 Europe Molecular Diagnosis of Tumors Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 7.3.3 France Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Molecular Diagnosis of Tumors Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Molecular Diagnosis of Tumors Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Molecular Diagnosis of Tumors Market Size by Region
  • 8.3.1 Asia-Pacific Molecular Diagnosis of Tumors Consumption Value by Region (2018-2029)
  • 8.3.2 China Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 8.3.5 India Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Molecular Diagnosis of Tumors Consumption Value by Type (2018-2029)
• 9.2 South America Molecular Diagnosis of Tumors Consumption Value by Application (2018-2029)
• 9.3 South America Molecular Diagnosis of Tumors Market Size by Country
  • 9.3.1 South America Molecular Diagnosis of Tumors Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Molecular Diagnosis of Tumors Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Molecular Diagnosis of Tumors Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Molecular Diagnosis of Tumors Market Size by Country
  • 10.3.1 Middle East & Africa Molecular Diagnosis of Tumors Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Molecular Diagnosis of Tumors Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Molecular Diagnosis of Tumors Market Drivers
• 11.2 Molecular Diagnosis of Tumors Market Restraints
• 11.3 Molecular Diagnosis of Tumors Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Molecular Diagnosis of Tumors Industry Chain
• 12.2 Molecular Diagnosis of Tumors Upstream Analysis
• 12.3 Molecular Diagnosis of Tumors Midstream Analysis
• 12.4 Molecular Diagnosis of Tumors Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source